DE3850306T2 - Camptothecin-Derivate und Verfahren zu ihrer Herstellung. - Google Patents

Camptothecin-Derivate und Verfahren zu ihrer Herstellung.

Info

Publication number
DE3850306T2
DE3850306T2 DE3850306T DE3850306T DE3850306T2 DE 3850306 T2 DE3850306 T2 DE 3850306T2 DE 3850306 T DE3850306 T DE 3850306T DE 3850306 T DE3850306 T DE 3850306T DE 3850306 T2 DE3850306 T2 DE 3850306T2
Authority
DE
Germany
Prior art keywords
group
lower alkyl
phenyl
camptothecin derivatives
lower alkoxy
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
DE3850306T
Other languages
English (en)
Other versions
DE3850306D1 (de
Inventor
Seigo Sawada
Kenichiro Nokata
Satoru Okajima
Hisako Nagai
Takashi Yaegashi
Kenichi Tezuka
Tadashi Miyasaka
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Yakult Honsha Co Ltd
Original Assignee
Yakult Honsha Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Yakult Honsha Co Ltd filed Critical Yakult Honsha Co Ltd
Application granted granted Critical
Publication of DE3850306D1 publication Critical patent/DE3850306D1/de
Publication of DE3850306T2 publication Critical patent/DE3850306T2/de
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
    • C07D471/12—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains three hetero rings
    • C07D471/14—Ortho-condensed systems

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
DE3850306T 1987-06-25 1988-06-24 Camptothecin-Derivate und Verfahren zu ihrer Herstellung. Expired - Fee Related DE3850306T2 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP15649587 1987-06-25

Publications (2)

Publication Number Publication Date
DE3850306D1 DE3850306D1 (de) 1994-07-28
DE3850306T2 true DE3850306T2 (de) 1994-10-06

Family

ID=15629001

Family Applications (1)

Application Number Title Priority Date Filing Date
DE3850306T Expired - Fee Related DE3850306T2 (de) 1987-06-25 1988-06-24 Camptothecin-Derivate und Verfahren zu ihrer Herstellung.

Country Status (7)

Country Link
US (1) US4914205A (de)
EP (1) EP0296612B1 (de)
KR (1) KR960004531B1 (de)
AT (1) ATE107649T1 (de)
CA (1) CA1332413C (de)
DE (1) DE3850306T2 (de)
ES (1) ES2058185T3 (de)

Families Citing this family (50)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5122526A (en) * 1987-03-31 1992-06-16 Research Triangle Institute Camptothecin and analogs thereof and pharmaceutical compositions and method using them
US5106742A (en) * 1987-03-31 1992-04-21 Wall Monroe E Camptothecin analogs as potent inhibitors of topoisomerase I
US5227380A (en) * 1987-03-31 1993-07-13 Research Triangle Institute Pharmaceutical compositions and methods employing camptothecins
US5364858A (en) * 1987-03-31 1994-11-15 Research Triangle Institute Camptothecin analogs as potent inhibitors of topoisomerase I
US5053512A (en) * 1987-04-14 1991-10-01 Research Triangle Institute Total synthesis of 20(S) and 20(R)-camptothecin and compthothecin derivatives
US5244903A (en) * 1987-03-31 1993-09-14 Research Triangle Institute Camptothecin analogs as potent inhibitors of topoisomerase I
US5340817A (en) * 1987-04-14 1994-08-23 Research Triangle Institute Method of treating tumors with anti-tumor effective camptothecin compounds
US5049668A (en) * 1989-09-15 1991-09-17 Research Triangle Institute 10,11-methylenedioxy-20(RS)-camptothecin analogs
US5122606A (en) * 1987-04-14 1992-06-16 Research Triangle Institute 10,11-methylenedioxy camptothecins
US5180722A (en) * 1987-04-14 1993-01-19 Research Triangle Institute 10,11-methylenedioxy-20(RS)-camptothecin and 10,11-methylenedioxy-20(S)-camptothecin analogs
WO1991004260A2 (en) * 1989-09-15 1991-04-04 Research Triangle Institute 10,11-methylenedioxy-20(rs)-camptothecin and 10,11-methylenedioxy-20(s)-camptothecin analogs
US5552154A (en) * 1989-11-06 1996-09-03 The Stehlin Foundation For Cancer Research Method for treating cancer with water-insoluble s-camptothecin of the closed lactone ring form and derivatives thereof
US5225404A (en) * 1989-11-06 1993-07-06 New York University Methods of treating colon tumors with tumor-inhibiting camptothecin compounds
US5883255A (en) * 1990-10-31 1999-03-16 Smithkline Beecham Corporation Substituted indolizino 1,2-b!quinolinones
US6080751A (en) * 1992-01-14 2000-06-27 The Stehlin Foundation For Cancer Research Method for treating pancreatic cancer in humans with water-insoluble S-camptothecin of the closed lactone ring form and derivatives thereof
US5446047A (en) * 1992-07-23 1995-08-29 Sloan-Kettering Institute For Cancer Research Camptothecin analogues
US5391745A (en) * 1992-07-23 1995-02-21 Sloan-Kettering Institute For Cancer Research Methods of preparation of camptothecin analogs
ZA936580B (en) * 1992-09-08 1994-08-01 Smithkline Beecham Corp Process for preparing certain pyrrolo (3 4-b)quinolines certain 1H-pyrano(3' 4':6,7)indolizino(1 2-b)quinolin-3 14(4H 12H)-diones and certain 8-methyl-7-(oxopropyl)-idolizino(1 2-b)quinolin-9(11H)-ones
US5352789A (en) * 1993-02-25 1994-10-04 The Stehlin Foundation For Cancer Research Methods for purifying camptothecin compounds
US5527913A (en) * 1993-02-25 1996-06-18 The Stehlin Foundation For Cancer Research Methods for purifying camptothecin compounds
AU684777B2 (en) * 1993-05-03 1998-01-08 Smithkline Beecham Corporation Substituted methylenedioxy(3',4':6,7)indolizino-(1,2-b)quinolinones
US5447936A (en) * 1993-12-22 1995-09-05 Bionumerik Pharmaceuticals, Inc. Lactone stable formulation of 10-hydroxy 7-ethyl camptothecin and methods for uses thereof
US5468754A (en) * 1994-04-19 1995-11-21 Bionumerik Pharmaceuticals, Inc. 11,7 substituted camptothecin derivatives and formulations of 11,7 substituted camptothecin derivatives and methods for uses thereof
US5604233A (en) * 1994-04-28 1997-02-18 Bionumerik Pharmaceuticals, Inc. Lactone stable formulation of 7-ethyl camptothecin and methods for uses thereof
US5597829A (en) * 1994-05-09 1997-01-28 Bionumerik Pharmaceuticals, Inc. Lactone stable formulation of camptothecin and methods for uses thereof
US5646159A (en) * 1994-07-20 1997-07-08 Research Triangle Institute Water-soluble esters of camptothecin compounds
JPH0873461A (ja) * 1994-09-06 1996-03-19 Yakult Honsha Co Ltd 新規なカンプトテシン誘導体、その製造法および抗腫瘍剤
US5614529A (en) * 1994-09-22 1997-03-25 Research Triangle Institute Inhibition of plasmodia parasites by camptothecin compounds
EP0835303A4 (de) * 1995-06-07 2000-09-13 Univ Jefferson Anti-pilz agenzien und methoden zu deren identifizierung und verwendung
AU7732996A (en) * 1995-11-22 1997-06-11 Research Triangle Institute Camptothecin compounds with combined topoisomerase i inhibition and dna alkylation properties
US6407118B1 (en) 1996-01-30 2002-06-18 The Stehlin Foundation For Cancer Research Derivatives of camptothecin and methods of treating cancer using these derivatives
US5731316A (en) * 1996-01-30 1998-03-24 The Stehlin Foundation For Cancer Research Derivatives of camptothecin and methods of treating cancer using these derivatives
US6096336A (en) * 1996-01-30 2000-08-01 The Stehlin Foundation For Cancer Research Liposomal prodrugs comprising derivatives of camptothecin and methods of treating cancer using these prodrugs
JP4094710B2 (ja) * 1997-11-06 2008-06-04 株式会社ヤクルト本社 新規なカンプトテシン誘導体
ID27253A (id) * 1998-08-05 2001-03-22 Aventis Pharma Sa Penggunaan turunan-turunan kampotesin dengan toksisitas gastrointestinal yang tereduksi
FR2792937B1 (fr) 1999-04-27 2001-08-10 Cemaf NOUVEAUX DERIVES DE PYRROLO-(3,4-b) QUINOLEINE, LEUR PROCEDE DE PREPARATION ET LEUR UTILISATION A TITRE DE MEDICAMENT
US6352996B1 (en) 1999-08-03 2002-03-05 The Stehlin Foundation For Cancer Research Liposomal prodrugs comprising derivatives of camptothecin and methods of treating cancer using these prodrugs
US6228855B1 (en) 1999-08-03 2001-05-08 The Stehlin Foundation For Cancer Research Aromatic esters of camptothecins and methods to treat cancers
AU775373B2 (en) 1999-10-01 2004-07-29 Immunogen, Inc. Compositions and methods for treating cancer using immunoconjugates and chemotherapeutic agents
ES2273841T3 (es) 2000-02-28 2007-05-16 Pfizer Enterprises Sarl Combinacion sinergica para el tratamiento de cancer colorrectal.
US6545010B2 (en) 2000-03-17 2003-04-08 Aventis Pharma S.A. Composition comprising camptothecin or a camptothecin derivative and a platin derivative for the treatment of cancer
US6548488B2 (en) 2000-03-17 2003-04-15 Aventis Pharma S.A. Composition comprising camptothecin or a camptothecin derivative and an alkylating agent for the treatment of cancer
US6486320B2 (en) 2000-09-15 2002-11-26 Aventis Pharma S.A. Preparation of camptothecin and of its derivatives
PL365685A1 (en) 2000-10-27 2005-01-10 Aventis Pharma S.A. A combination comprising camptothecin and a stilbene derivative for the treatment of cancer
US6608076B1 (en) 2002-05-16 2003-08-19 Enzon, Inc. Camptothecin derivatives and polymeric conjugates thereof
CZ299329B6 (cs) * 2003-08-26 2008-06-18 Pliva-Lachema A.S. Zpusob výroby 7-ethyl-10-[ 4-(1-piperidino)-1-piperidino]karbonyloxykamptothecinu
CZ299593B6 (cs) * 2003-12-16 2008-09-10 Pliva-Lachema A. S. Zpusob výroby 7-ethyl-10-hydroxykamptothecinu
WO2006069344A2 (en) 2004-12-22 2006-06-29 Rutgers, The State University Of New Jersey Controlled release hydrogels
US8410045B2 (en) 2006-03-30 2013-04-02 Drais Pharmaceuticals, Inc. Camptothecin-peptide conjugates and pharmaceutical compositions containing the same
US20140086975A1 (en) 2010-10-15 2014-03-27 Rutgers, The State University Of New Jersey Hydrogel formulation for dermal and ocular delivery

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US32518A (en) * 1861-06-11 Improvement in city railroads
JPS5198300A (en) * 1975-02-20 1976-08-30 Kanputoteshin oyobi sonoruijitaino seizoho
DE2534601A1 (de) * 1975-08-02 1977-02-17 Basf Ag Verfahren zur herstellung von camptothecin-aehnlichen verbindungen
US4399282A (en) * 1979-07-10 1983-08-16 Kabushiki Kaisha Yakult Honsha Camptothecin derivatives
JPS58154582A (ja) * 1982-03-10 1983-09-14 Yakult Honsha Co Ltd 新規なカンプトテシン誘導体およびその製造法

Also Published As

Publication number Publication date
CA1332413C (en) 1994-10-11
ES2058185T3 (es) 1994-11-01
KR960004531B1 (ko) 1996-04-06
KR890000485A (ko) 1989-03-15
EP0296612A1 (de) 1988-12-28
ATE107649T1 (de) 1994-07-15
US4914205A (en) 1990-04-03
EP0296612B1 (de) 1994-06-22
DE3850306D1 (de) 1994-07-28

Similar Documents

Publication Publication Date Title
DE3850306D1 (de) Camptothecin-Derivate und Verfahren zu ihrer Herstellung.
DE68906552D1 (de) Camptothecin-derivate und verfahren zu ihrer herstellung.
ATE240314T1 (de) Kristalle von benzimidazolderivate und verfahren zu ihrer herstellung
ATE113281T1 (de) Pyrazol-derivate, verfahren zu deren herstellung und anwendung.
DK0487071T3 (da) Kondenserede heterocykliske forbindelser, deres fremstilling og anvendelse
DE3767672D1 (de) Chinazolinonderivat und verfahren zu seiner herstellung.
ATE123494T1 (de) Chinolon-derivate und deren salze, verfahren zu deren herstellung und diese enthaltende antibakterielle wirkstoffe.
DE3864707D1 (de) Benzoxazin-derivate und verfahren zu ihrer herstellung.
PT85688A (de) Neue naphthylderivate diese verbindungen enthaltende arzneimittel und verfahren zu ihrer herstellung
ATE113594T1 (de) Verfahren zur herstellung von sulfonylharnstoff- derivaten.
ATE75737T1 (de) Indenothiazolderivate und verfahren zu ihrer herstellung.
ATE58532T1 (de) (2-amino-4-aryl-thiazol-5-yl)aethanol, und deren derivate mit diuretischer aktivitaet und verfahren zu deren herstellung.
HU903266D0 (en) Process for producing amine-derivatives and pharmaceutical preparatives containing these compounds as active substance
DE3852506T2 (de) Verfahren zur Herstellung von Halogensulfonyl-substituierten Pyridinen.
EP0726269A4 (de) Quinolincarbonsäurederivat une seine salze
DE3861928D1 (de) Ein thiophenderivat und verfahren zu dessen herstellung.
ATE118762T1 (de) Verfahren zur herstellung von 4- methylsulfonylbenzoesäurederivate und zwischenprodukte.
ATE25680T1 (de) Verfahren zur herstellung von 4-amino-5-dialkoxy- methylpyrimidinderivaten.
DE69022660D1 (de) Verfahren zur Herstellung von Carbamatderivaten des Lankacidines.
DE3680807D1 (de) Dioxolobenzisoxazolderivate und verfahren zu ihrer herstellung.
ATE117689T1 (de) Verfahren zur herstellung von lactamderivaten.
ATE135693T1 (de) Halogeno-4-methylpyrazole und verfahren zu ihrer herstellung
KR840001154A (ko) 1,2-디티올-3-일리덴 암모늄 유도체의 제조방법
ATE162522T1 (de) Verfahren zur herstellung von heterocyclischen derivaten
ATE57934T1 (de) Verfahren zur herstellung von griseolinsaeurederivaten.

Legal Events

Date Code Title Description
8364 No opposition during term of opposition
8339 Ceased/non-payment of the annual fee